Sage Clinical Medicine & Research

Dr Massimo Di Nicola and Dr Federico Stella discuss the role of adoptive T-cell therapy in solid tumors. The speech starts with a general discussion about immunotherapy and mechanism of resistance. Among the strategies implemented in order to overcome resistance to immunotherapy, the adoptive T-cells are promising. Thus, the discussion translate from the bench of an immunology lab to the bedside of an oncological unit where CAR T-cells offers opportunity and challenges